Position in BVS
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$238,048
-$464,994 QoQ
Shares Held
25,217
-57.1% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#92
of 155 holders
Holding Since
Dec 2021
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BVS Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026GSA CAPITAL PARTNERS LLP holds $34,102,577 across 41 Medical Devices names. BVS ranks #35 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDT |
Medtronic plc
|
68,541 | $5,361,962 | |
| 2 | NPCE |
NeuroPace Inc
|
115,535 | $1,835,851 | |
| 3 | QTRX |
Quanterix Corp
|
410,252 | $1,772,288 | |
| 4 | PODD |
Insulet Corp
|
11,310 | $1,721,947 | |
| 5 | INFU |
InfuSystem Holdings, Inc
|
160,439 | $1,548,236 | |
| 6 | VMD |
Viemed Healthcare, Inc.
|
127,591 | $1,454,537 | |
| 7 | BSX |
Boston Scientific Corp
|
32,095 | $1,369,814 | |
| 8 | DXCM |
Dexcom Inc
|
19,820 | $1,334,877 |
All Filings in BVS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $238,048 | 25,217 | Shares | Sole | 2026-08-06 | |
| 2024-09-30 | $703,042 | 58,832 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $182,275 | 31,700 | Shares | Sole | 2024-08-15 | |
| 2021-12-31 | $197,368 | 13,621 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||